Ultime notizie per Zenvia (NASDAQ:ZENV) Azioni

Zenvia

Zenvia Inc provides a platform that enables companies to create unique journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.

Zenvia Inc

JP Morgan analyst Jessica Fye maintains Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) with a Overweight and lowers the price target from $510 to $503.

News

Price Target

Analyst Ratings

VRTX

JP Morgan Maintains Overweight on Vertex Pharmaceuticals, Lowers Price Target to $503

WIIM

Diversified Healthcare Trust shares are trading lower after the company reported worse-than-expected Q3 financial results.

Keefe, Bruyette &amp; Woods analyst Jade Rahmani maintains Meritage Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTH#NYSE">MTH</a>) with a Market Perform and lowers the price target from $210 to $198.

Keefe, Bruyette & Woods Maintains Market Perform on Meritage Homes, Lowers Price Target to $198

JP Morgan analyst Peter Peng maintains Silicon Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) with a Overweight and lowers the price target from $150 to $135.

SLAB

JP Morgan Maintains Overweight on Silicon Laboratories, Lowers Price Target to $135

RBC Capital analyst Conor McNamara maintains Illumina (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>) with a Outperform and raises the price target from $252 to $254.

ILMN

RBC Capital Maintains Outperform on Illumina, Raises Price Target to $254

Keefe, Bruyette &amp; Woods analyst Sanjay Sakhrani maintains Marqeta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MQ#NASDAQ">MQ</a>) with a Market Perform and lowers the price target from $6 to $5.

Keefe, Bruyette & Woods Maintains Market Perform on Marqeta, Lowers Price Target to $5

SANA

Sana Biotechnology shares are trading lower after JMP Securities downgraded the stock from Market Outperform to Market Perform. Also, HC Wainwright & Co. lowered its price target from $11 to $8.

JP Morgan analyst Samik Chatterjee maintains Sensata Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>) with a Underweight and lowers the price target from $34 to $32.

JP Morgan Maintains Underweight on Sensata Technologies, Lowers Price Target to $32

Keefe, Bruyette &amp; Woods analyst Vasundhara Govil maintains Fidelity National Info (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>) with a Outperform and raises the price target from $97 to $102.

Keefe, Bruyette & Woods Maintains Outperform on Fidelity National Info, Raises Price Target to $102

DXPE

DXP Enterprises shares are trading higher after the company reported better-than-expected Q3 financial results.

The U.S. services sector's economic momentum is firing at all cylinders, with business activity in October reaching its strongest level <a href="https://www.benzinga.com/news/econ-s">in over two years.</a>
According to the Institute for Supply Management, the Services PMI surged to 56% in October 2024, up from 54.9% in September, defying expectations of a dip to 53.8%.
This result marks the fastest pace of expansion in the U.S. services sector since August 2022. The ISM Services PMI has shown growth in 20 of the past 22 months since January 2023, with October's reading standing 3.7 percentage points above the 2024 average of 52.3%.
&#8220;The increase in the Services PMI&nbsp;in October was driven by boosts of more than 4 percentage points for both the Employment and Supplier Deliveries indexes. The Business Activity and New Orders indexes both dropped by at least 2 percentage points. Each of the four subindexes are now above their averages for 2024,&#8221; stated Steve Miller, chair of the ISM Services Business Survey Committee, said.
<h3 class="wp-block-heading">ISM Services PMI For October: Key Highlights</h3>
<ul>
<li>The subindex for Business Activity eased from 59.9% to 57.2% in October.</li>
<li>The subindex for New Orders eased from 59.4% to 57.4% in October. </li>
<li>The subindex for Prices eased from 59.4% to 58.1%. </li>
<li>The subindex for Employment rose from 48.1% to 53%, well above the expected 48%. The outcome marked the highest level in employment index since September 2023. </li>
</ul>
&#8220;Concerns over political uncertainty were again more prevalent than the previous month. Impacts from hurricanes and ports labor turbulence were mentioned frequently, although several panelists mentioned that the longshoremen's strike had less of an impact than feared due to its short duration,&#8221; Miller added. 
<h3 class="wp-block-heading">Market Reactions</h3>
On Tuesday, U.S. stocks rebounded as investors reacted positively to the latest ISM Services PMI data, alleviating earlier political concerns as Americans headed to the polls to elect the 47th president.
The S&amp;P 500, represented by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), rose 0.8%. The tech-heavy Nasdaq 100, tracked by the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), rallied nearly 1%, while the SPDR Dow Jones Industrial Average ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) edged 0.6% higher.
Yields on 10-year Treasury bonds rose 7 basis points to 4.36%. The iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) fell 0.5%. 
The U.S. dollar index — as tracked by the  Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>) — weakened 0.5%.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/asia/24/11/41722178/if-trump-and-republicans-sweep-dollar-may-climb-7-but-harris-win-could-bring-5-drop-says-jpmorgan">If Trump And Republicans Sweep, Dollar May Climb 7% — But Harris Win Could Bring 5% Drop, Says JPMorgan</a></li>
</ul>
Image: Shutterstock

Macro Economic Events

Bonds

Broad U.S. Equity ETFs

Treasuries

Econ #s

Economics

ETFs

SPDR Dow Jones Industrial Average ETF Trust

iShares Trust Barclays 20+ Year Treasury Bond Fund

PowerShares DB US Dollar Index Bullish Fund

US Services Sector Gauge Rises More Than Expected To Over 2-Year Highs As Employment Index Defies Hurricane Shocks

Cushman & Wakefield shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results.

REAL

The RealReal shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 revenue guidance above estimates.

JP Morgan analyst Tien-Tsin Huang maintains Marqeta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MQ#NASDAQ">MQ</a>) with a Neutral and lowers the price target from $6 to $5.

JP Morgan Maintains Neutral on Marqeta, Lowers Price Target to $5

Keefe, Bruyette &amp; Woods analyst Aidan Hall reiterates Franklin Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEN#NYSE">BEN</a>) with a Underperform and lowers the price target from $20 to $19.

Reiteration

Keefe, Bruyette & Woods Reiterates Underperform on Franklin Resources, Lowers Price Target to $19

RBC Capital analyst Luca Issi maintains Adverum Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADVM#NASDAQ">ADVM</a>) with a Sector Perform and lowers the price target from $12 to $10.

ADVM

RBC Capital Maintains Sector Perform on Adverum Biotechnologies, Lowers Price Target to $10

BWIN

The Baldwin Insurance Group shares are trading lower after the company reported worse-than-expected Q3 financial results. Also, Wells Fargo maintained an Equal-Weight rating on the stock and lowered its price target from $46 to $43.

JP Morgan analyst Anne Samuel maintains IQVIA Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) with a Overweight and lowers the price target from $279 to $240.

JP Morgan Maintains Overweight on IQVIA Hldgs, Lowers Price Target to $240

Hyster-Yale shares are trading lower after the company reported worse-than-expected Q3 financial results. The company also issued expectations for FY25 revenues to be lower than 2024 and for operating profit and net income to decline significantly.

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains Brookfield Asset Mgmt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAM#NYSE">BAM</a>) with a Underperform and raises the price target from $44 to $49.

Keefe, Bruyette & Woods Maintains Underperform on Brookfield Asset Mgmt, Raises Price Target to $49

Zenvia reports Q2 results

Cesar Medina, an analyst from Morgan Stanley, maintained the Hold rating on Zenvia (ZENV – Research Report). The associated price target is $2.00. ...

Maintaining Hold on Zenvia: Weighing Operational Success Against Financial Uncertainties

Zenvia Inc. (ZENV) Q2 2024 Earnings Call Transcript

Zenvia (ZENV) has released an update. Zenvia Inc., a Brazil-based company, has submitted a report to the U.S. Securities and Exchange Commission (S...

Zenvia Inc. Complies with SEC's September Filing

Zenvia (ZENV) has released an update. Zenvia Inc., a Brazil-based tech company, reported its unaudited interim condensed consolidated financial res...

Zenvia Inc. Reports Mid-Year Financial Performance

Zenvia (ZENV) has released an update. Zenvia Inc. reports strong financial performance in Q2 2024, with a 19.8% year-over-year revenue increase and...

Zenvia Inc. Soars with Robust Q2 2024 Earnings

Warning: ZENV is at high risk of performing badly

Zenvia (ZENV) has released an update. Zenvia Inc., a leading cloud-based customer experience platform in Latin America, announced the resignation o...

Zenvia Inc. Announces Leadership Change in Marketing

ZENV

Earnings

Press Releases

ZENVIA Reports Q3 2023 and 9M 2023 Results

Zenvia Announces Agreements to Address Funding Gap and Introduces EBITDA Guidance for 2024

ZENVIA sets agenda for fiscal fourth quarter and full year results

ZENVIA Reports Q4 2023 and FY 2023 Results

Zenvia Files its Annual Report on Form 20-F for Fiscal Year 2023

Zenvia unveils its cutting-edge Generative AI Chatbot solution, revolutionizing the interaction landscape between brands and consumers

ZENVIA Reports Q1 2024 Results

ZENVIA sets agenda for fiscal second quarter and first half 2024 results

ZENVIA Reports Q2 2024 and H1 2024 Results

Zenvia Customer Cloud hits the market with AI to revolutionize Brand-Customer experiences

ReAlpha Tech

Argo Blockchain plc - American Depositary Shares

Argo Blockchain

Arqit Quantum

Gorilla Technology Group Inc. - Ordinary shares

Gorilla Tech Gr

MicroCloud Hologram Inc. - Ordinary Shares

MicroCloud Hologram

Intellicheck

Inuvo

Issuer Direct

Aurora Mobile Limited - American Depositary Shares

Aurora Mobile

LivePerson

WM Technology, Inc. - Class A Common Stock

WM Tech

Mercurity Fintech Holding Inc. - American Ordinary Shares

Mercurity Fintech Holding

MMTEC

The9 Limited - American Depository Shares

The9

NiSun Intl Enterprise Development Group Co, Ltd - Class A Common Shares

NiSun Intl Enterprise Dev

NETSOL Technologies

OneConnect Financial Technology Co., Ltd. American Depositary Shares, each representing thirty ordinary shares

Comments

Zenvia

Notizie

Ultime notizie per Zenvia (NASDAQ:ZENV) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO